The psychological burden associated with prostate cancer and its treatment is increasingly recognised by clinicians, patients, and their families. Men with prostate cancer are reported to have a higher risk of anxiety, depression and suicide than their peers. Thus, routine screening for distress, anxiety, and depression is an important part of clinical care. The extent to which screening can improve outcomes for men with prostate cancer is dependent on the provision of quality evidence-based interventions that are responsive to their needs. In this presentation, recent evidence for psychosocial interventions will be considered from published reviews to pilot studies. Attention will be given to the intervention types, modes of delivery (online vs face-to-face), and settings of effective interventions.